March 7, 2024Biomedical PhotonicsOpen Access

Photodynamic therapy of Bowen’s disease

View Full Paper

Ask AI

Bookmark

Complete regression of pathologic foci occurs frequently with photodynamic therapy, providing superior cosmetic outcomes compared with traditional local treatments.
Complete response rates reach 67% to 100% across treated lesions, while observed recurrence of bowen disease remains between 2% and 28% in published clinical trials.
Review of published clinical data highlights that aminolevulinic acid achieves durable disease control, supporting its use when surgical intervention is not feasible.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Literature review demonstrates high clinical efficacy of photodynamic therapy in Bowen disease patients, highlighting its therapeutic value when surgery is not feasible.

Cite This Study

Филоненко et al. (2024) studied this question.

synapsesocial.com/papers/68e75433b6db6435876cc3ba https://doi.org/10.24931/2413-9432-2023-12-4-22-29

View Full Paper

Ask AI

Bookmark

Implication

Literature review demonstrates high clinical efficacy of photodynamic therapy in Bowen disease patients, highlighting its therapeutic value when surgery is not feasible.

Photodynamic therapy of Bowen’s disease

Key Points

Discussion

Implication

Cite This Study

Photodynamic therapy of Bowen’s disease

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider